Xiang lab - new publication in Cell Mol Immunol

TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis

Authors: Xu A, Zhang L, Yuan J, Babikr F, Freywald A, Chibbar R, Moser M, Zhang W, Zhang B, Fu Z, Xiang J. Cell Mol Immunol. 2019 Oct;16(10):820-832.

PMID: 30467420

 

This paper can be accessed here.